Continuum Advisory’s ProShares Ultra Technology ROM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,960
Closed -$741K 417
2022
Q1
$741K Sell
19,960
-17,382
-47% -$864K 0.14% 186
2021
Q4
$2.38M Buy
37,342
+5,270
+16% +$314K 0.53% 44
2021
Q3
$1.59M Buy
32,072
+4,432
+16% +$235K 0.43% 57
2021
Q2
$1.33M Buy
27,640
+200
+0.7% +$8.5K 0.41% 62
2021
Q1
$1.21M Buy
27,440
+2,300
+9% +$86.6K 0.5% 56
2020
Q4
$901K Buy
25,140
+17,700
+238% +$565K 0.41% 66
2020
Q3
$217K Sell
7,440
-2,800
-27% -$76.5K 0.12% 135
2020
Q2
$242K Buy
+10,240
New +$196K 0.15% 117
2020
Q1
Sell
-14,320
Closed -$285K 152
2019
Q4
$285K Hold
14,320
0.17% 107
2019
Q3
$216K Sell
14,320
-800
-5% -$12.3K 0.14% 115
2019
Q2
$229K Buy
15,120
+480
+3% +$6.94K 0.16% 109
2019
Q1
$208K Buy
+14,640
New +$177K 0.16% 119
2018
Q4
Sell
-15,776
Closed -$239K 172
2018
Q3
$239K Buy
+15,776
New +$226K 0.16% 129

Other funds holding ROM

Continuum Advisory's ROM Position: Q2 2022 in Review

Continuum Advisory sold out of ProShares Ultra Technology (ROM) in Q2 2022, closing a stake of 19,960 shares — an estimated $741K sold.

Continuum Advisory first reported a position in ROM in Q3 2018 and held it in 13 quarters. The position peaked at $2.38M in Q4 2021. 37 funds tracked by Wall St. Rank hold ROM as of Q2 2022.

  • Continuum Advisory reported no remaining ProShares Ultra Technology position as of Q2 2022 after selling out during the quarter.
  • Continuum Advisory sold 19,960 ProShares Ultra Technology shares in Q2 2022, an estimated $741K.
  • Continuum Advisory first reported a position in ProShares Ultra Technology in Q3 2018 and held it in 13 quarters.
  • Continuum Advisory's ProShares Ultra Technology position peaked at $2.38M in Q4 2021.
  • 37 funds tracked by Wall St. Rank held ProShares Ultra Technology as of Q2 2022.

Based on Continuum Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.